BACKGROUND: Characterization of long-term health trajectory in older individuals is important for proactive health management. However, the relative prognostic value of information contained in clinical profiles of nonfrail older adults is often unclear. METHODS: We screened 825 phenotypic and genetic measures evaluated during the Health, Aging, and Body Composition Study (Health ABC) baseline visit (3,067 men and women aged 70-79). Variables that best predicted mortality over 13 years of follow-up were identified using 10-fold cross-validation. RESULTS: Mortality was most strongly associated with low Digit Symbol Substitution Test (DSST) score (DSST<25; 21.9% of cohort; hazard ratio [HR]=1.87±0.06) and elevated serum cystatin C (≥1.30 mg/mL; 12.1% of cohort; HR=2.25±0.07). These variables predicted mortality better than 823 other measures, including baseline age and a 45-variable health deficit index. Given elevated cystatin C (≥1.30 mg/mL), mortality risk was further increased by high serum creatinine, high abdominal visceral fat density, and smoking history (2.52≤HR ≤3.73). Given a low DSST score (<25) combined with low-to-moderate cystatin C (<1.30 mg/mL), mortality risk was highest among those with elevated plasma resistin and smoking history (1.90≤HR≤2.02). CONCLUSIONS: DSST score and serum cystatin C warrant priority consideration for the evaluation of mortality risk in older individuals. Both variables, taken individually, predict mortality better than chronological age or a health deficit index in well-functioning older adults (ages 70-79). DSST score and serum cystatin C can thus provide evidence-based tools for geriatric assessment.
BACKGROUND: Characterization of long-term health trajectory in older individuals is important for proactive health management. However, the relative prognostic value of information contained in clinical profiles of nonfrail older adults is often unclear. METHODS: We screened 825 phenotypic and genetic measures evaluated during the Health, Aging, and Body Composition Study (Health ABC) baseline visit (3,067 men and women aged 70-79). Variables that best predicted mortality over 13 years of follow-up were identified using 10-fold cross-validation. RESULTS: Mortality was most strongly associated with low Digit Symbol Substitution Test (DSST) score (DSST<25; 21.9% of cohort; hazard ratio [HR]=1.87±0.06) and elevated serum cystatin C (≥1.30 mg/mL; 12.1% of cohort; HR=2.25±0.07). These variables predicted mortality better than 823 other measures, including baseline age and a 45-variable health deficit index. Given elevated cystatin C (≥1.30 mg/mL), mortality risk was further increased by high serum creatinine, high abdominal visceral fat density, and smoking history (2.52≤HR ≤3.73). Given a low DSST score (<25) combined with low-to-moderate cystatin C (<1.30 mg/mL), mortality risk was highest among those with elevated plasma resistin and smoking history (1.90≤HR≤2.02). CONCLUSIONS: DSST score and serum cystatin C warrant priority consideration for the evaluation of mortality risk in older individuals. Both variables, taken individually, predict mortality better than chronological age or a health deficit index in well-functioning older adults (ages 70-79). DSST score and serum cystatin C can thus provide evidence-based tools for geriatric assessment.
Authors: L P Fried; R A Kronmal; A B Newman; D E Bild; M B Mittelmark; J F Polak; J A Robbins; J M Gardin Journal: JAMA Date: 1998-02-25 Impact factor: 56.272
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: E M Simonsick; A B Newman; M C Nevitt; S B Kritchevsky; L Ferrucci; J M Guralnik; T Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2001-10 Impact factor: 6.053
Authors: Neil S Wenger; David H Solomon; Carol P Roth; Catherine H MacLean; Debra Saliba; Caren J Kamberg; Laurence Z Rubenstein; Roy T Young; Elizabeth M Sloss; Rachel Louie; John Adams; John T Chang; Patricia J Venus; John F Schnelle; Paul G Shekelle Journal: Ann Intern Med Date: 2003-11-04 Impact factor: 25.391
Authors: Valory N Pavlik; Suzana Alves de Moraes; Moyses Szklo; David S Knopman; Thomas H Mosley; David J Hyman Journal: Am J Epidemiol Date: 2003-02-15 Impact factor: 4.897
Authors: Matthew D L O'Connell; Megan M Marron; Robert M Boudreau; Mark Canney; Jason L Sanders; Rose Anne Kenny; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2019-04-23 Impact factor: 6.053
Authors: Megan M Marron; Iva Miljkovic; Robert M Boudreau; Kaare Christensen; Mary F Feitosa; Joseph H Lee; Paola Sebastiani; Bharat Thyagarajan; Mary K Wojczynski; Joseph M Zmuda; Anne B Newman Journal: Metabolism Date: 2019-01-30 Impact factor: 8.694
Authors: Caterina Rosano; Yue-Fang Chang; Lewis H Kuller; Jack M Guralnik; Stephanie A Studenski; Howard J Aizenstein; Peter J Gianaros; Oscar L Lopez; William T Longstreth; Anne B Newman Journal: Psychosom Med Date: 2013-07-25 Impact factor: 4.312
Authors: Marissa E Sakoda; Pariya L Fazeli; Ronald J Ellis; Dilip V Jeste; Igor Grant; Scott L Letendre; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Megan M Marron; Diane G Ives; Robert M Boudreau; Tamara B Harris; Anne B Newman Journal: J Am Geriatr Soc Date: 2018-09-12 Impact factor: 5.562
Authors: Nelson Mauro Maldonato; Raffaele Sperandeo; Giovanni Caiazzo; Valeria Cioffi; Pasquale Cozzolino; Rosa Maria De Santo; Maria Luigia Fusco; Vittoria Silviana Iorio; Elena Gigante; Patrizia Marone; Nicole Nascivera; Chiara Scognamiglio Journal: PLoS One Date: 2018-06-01 Impact factor: 3.240